Signal from the log
Loyal
100 M$ · Series C · United States · Pharma
Société américaine qui développe des médicaments allongeant la durée de vie en bonne santé des CHIENS, et non des humains : son candidat LOY-002 est une pilule quotidienne agissant sur les voies métaboliques du vieillissement. Le tour finance la fin du parcours réglementaire vétérinaire.
Verified
Announced on , logged by the watch of 12 August 2026.
- Operation
- Funding round
- Announced amount
- 100 M$
- Stage
- Series C
- Country
- United States
- Sector
- Pharma
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
With Baillie Gifford
Provenance
Source longevity
Logged on 12 August 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.